9th Annual Life Science Strengthening Patient Advocacy Engagement Conference

July, 2020 | Philadelphia, PA
Request Invite

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

“Thanks so much for your great work in making this patient advocacy conference in Baltimore a terrific experience!”

Patient Advocacy Manager
Milestone Pharmaceuticals USA

“I appreciate the innovative thought that resulted my invitation to present & collaborate on [Patient advocacy]. I learned a lot about an industry and roles that impact my work.”

VP Population Health
Blue Cross Blue Shield of Tennessee

“Great conference with knowledge sharing and networking.”

Senior Director, Advocacy
Alzheimer’s Association

“It was helpful to hear so many different perspectives and also recognizing similarities. Thanks for having me!”

Global Outreach and Education Coordinator
Allergy & Asthma Network

About the Conference:

The role and prominence of patient advocacy efforts continues to increase, as advocacy executives interact with external stakeholders from early product concept and throughout the commercialization of products, bringing the patient perspective into product development and research all the way to collection of post-market outcomes data. At the same time, pressure throughout the industry, from pricing and reimbursement and the focus on value-based care to corporate compliance concerns surrounding appropriate actions and support of external stakeholders requires a thoughtful balance and well considered approach.

Topics to Be Addressed:

  • Linking advocacy efforts to product development & commercialization
  • Compliance requirements in expanding advocacy outreach efforts
  • Effective communication & outreach to lay persons & caregivers
  • Innovative engagement between industry and advocacy groups
  • Use of new technology & innovation in advocacy programs

Program Highlights:

  • Balance of perspectives includes varied stakeholders including:
    • Life science corporations
    • Large & small patient groups
    • FDA regulatory perspectives
    • Legal & compliance experts
  • Content driven agenda focused on collaboration & knowledge share
  • Actionable case studies with a problem solving, solutions focus

Audience

75 Attendees

All attendees come directly from life science companies

Distinguished Presenters

Speaker recruitment in progress

Networking

Networking time is built into the agenda to allow industry peers to connect and exchange ideas

Open Dialogue and Group Share

Each presentation is followed by 10-15 minutes of open dialogue for questions and exchange of best practices

Share This